Issue - meetings

1.  The contract for the Bromley Substance Misuse Service be awarded to the Service Provider named in the Part Two Report, commencing 1st April 2024 for five years with an option to extend for up to a further three years at an estimated contract value as detailed in the Part Two report.

2.  Authority be delegated to the Chief Officer (Director of Public Health), subject to agreement with the Portfolio Holder, the Assistant Director Governance & Contracts, the Director of Finance and Director of Corporate Services and Governance, to apply the three year extension in due course.

3.  Authority be delegated to the Chief Officer (Director of Public Health), subject to agreement with the Portfolio Holder and the Director of Finance, to draw down expected Supplemental Substance Misuse Treatment and Recovery (SSMTR) Grants and future potential Substance Misuse grants that may be allocated by the Office for Health Improvements and Disparities (OHID) during the life of the contract.

4.  Authority be delegated to the Chief Officer, subject to agreement with the Portfolio Holder, the Assistant Director Governance & Contracts, the Director of Finance and Director of Corporate Services and Governance, to vary the Substance Misuse Provider Service contract as required to incorporate additional requirements linked to the allocation of the SSMTR grant and other future Substance Misuse grants that may be allocated.

Report ACH23-033

The Executive agreed on 30^th November 2022 (Report ACH22-037) to proceed to procurement for the Bromley Substance Misuse Provider Service.  The report detailed the outcome of the tender process and recommended contract award.

The report had been scrutinised by the Adult Care and Health PDS Committee at its meeting on 5 September 2023 and the Committee had supported the recommendations.

RESOLVED: That

1.  The contract for the Bromley Substance Misuse Service be awarded to the Service Provider named in the Part Two Report, commencing 1st April 2024 for five years with an option to extend for up to a further three years at an estimated contract value as detailed in the Part Two report.

2.  Authority be delegated to the Chief Officer (Director of Public Health), subject to agreement with the Portfolio Holder, the Assistant Director Governance & Contracts, the Director of Finance and Director of Corporate Services and Governance, to apply the three year extension in due course.

3.  Authority be delegated to the Chief Officer (Director of Public Health), subject to agreement with the Portfolio Holder and the Director of Finance, to draw down expected Supplemental Substance Misuse Treatment and Recovery (SSMTR) Grants and future potential Substance Misuse grants that may be allocated by the Office for Health Improvements and Disparities (OHID) during the life of the contract.

4.  Authority be delegated to the Chief Officer, subject to agreement with the Portfolio Holder, the Assistant Director Governance & Contracts, the Director of Finance and Director of Corporate Services and Governance, to vary the Substance Misuse Provider Service contract as required to incorporate additional requirements linked to the allocation of the SSMTR grant and other future Substance Misuse grants that may be allocated.

Report ACH23-033

The Committee considered a report seeking Executive approval for an award of contract for the Substance Misuse Service.

On 30^th November 2022 (Report ACH22-037) the Executive agreed to proceed to procurement for the Bromley Substance Misuse Provider Service. The report provided details of the outcome of the tender process and recommended contract award.

RESOLVED that the Executive be recommended to:

i.)  Approve the award of contract for the Bromley Substance Misuse Service to the Service Provider named in the Part Two Report, commencing 1^st April 2024 for five years with an option to extend for up to a further three years at an estimated contract value as detailed in the Part Two report;

ii.)  Approve delegated authority to the Chief Officer, subject to agreement with the Portfolio Holder, the Assistant Director Governance & Contracts, the Director of Finance and Director of Corporate Services, to apply the three-year extension in due course;

iii.)  Approve delegated authority to the Chief Officer, subject to agreement with the Portfolio Holder and the Director of Finance, to draw down expected Supplemental Substance Misuse Treatment and Recovery (SSMTR) Grants and future potential Substance Misuse grants that may be allocated by the Office for Health Improvements and Disparities (OHID) during the life of the contract; and,

iv.)  Approve delegated authority to the Chief Officer, subject to agreement with the Portfolio Holder, the Assistant Director Governance & Contracts, the Director of Finance and Director of Corporate Services, to vary the Substance Misuse Provider Service contract as required to incorporate additional requirements linked to the allocation of the SSMTR grant and other future Substance Misuse grants that may be allocated.